Literature DB >> 21225535

[Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres].

H J Schlitt1, M Loss, M N Scherer, T Becker, K-W Jauch, B Nashan, H Schmidt, U Settmacher, X Rogiers, P Neuhaus, C Strassburg.   

Abstract

Liver transplantation represents a successful and well-established therapeutic concept for patients with advanced liver diseases. Organ donor shortage continues to pose a significant problem. To ensure fair and transparent allocation of too few post-mortem grafts, the model of end-stage liver disease (MELD)-based allocation was implemented in December 2006. This has decreased waiting list mortality from 20 to 10 % but at the same time has reduced post OLT survival (1-year survival from almost 90% to below 80%), which is largely due to patients with a labMELD score > 30. Following MELD introduction the regular allocation threshold has increased from a matchMELD of initially 25 to meanwhile 34. At the same time the quality of donor organs has seen a continuous deterioration over the last 10 - 15 years: 63% of organs are "suboptimal" with a donor risk index of > 1.5. Moreover, the numbers of living-related liver transplantations have decreased. In Germany incentives for transplant centres are inappropriate: patients with decompensated cirrhosis, high MELD scores and high post-transplant mortality as well as marginal liver grafts are accepted for transplantation without the necessary consideration of outcomes, and against a background of the still absent publication and transparency of outcome results. The outlined development calls for measures for improvement: (i) the increase of donor grafts (e. g., living donation, opt-out solutions, non-heart beating donors), (ii) the elimination of inappropriate incentives for transplant centres, (iii) changes of allocation guidelines, that take the current situation and suboptimal donor grafts into account, and (iv) the systematic and complete collection of transplant-related data in order to allow for the development of improved prognostic scores. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21225535     DOI: 10.1055/s-0029-1245946

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  33 in total

1.  Value of the SOFA score as a predictive model for short-term survival in high-risk liver transplant recipients with a pre-transplant labMELD score ≥ 30.

Authors:  Harald Schrem; Melanie Reichert; Benedikt Reichert; Thomas Becker; Frank Lehner; Moritz Kleine; Hüseyin Bektas; Kai Johanning; Christian P Strassburg; Jürgen Klempnauer
Journal:  Langenbecks Arch Surg       Date:  2011-12-06       Impact factor: 3.445

Review 2.  [Liver transplantation for hilar cholangiocarcinoma].

Authors:  F Rauchfuss; F Utess; S Schüle; Y Dittmar; H Scheuerlein; U Settmacher
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

3.  Liver cirrhosis, transplantation and organ shortage.

Authors:  Michael P Manns
Journal:  Dtsch Arztebl Int       Date:  2013-02-08       Impact factor: 5.594

Review 4.  [Deceased donor liver transplantation].

Authors:  D Seehofer; W Schöning; P Neuhaus
Journal:  Chirurg       Date:  2013-05       Impact factor: 0.955

5.  Application of the BAR score as a predictor of short- and long-term survival in liver transplantation patients.

Authors:  Ivan Dias de Campos Junior; Raquel Silveira Bello Stucchi; Elisabete Yoko Udo; Ilka de Fátima Santana Ferreira Boin
Journal:  Hepatol Int       Date:  2014-08-09       Impact factor: 6.047

Review 6.  Irreversible liver failure: treatment by transplantation: part 3 of a series on liver cirrhosis.

Authors:  Andreas Pascher; Maxim Nebrig; Peter Neuhaus
Journal:  Dtsch Arztebl Int       Date:  2013-03-08       Impact factor: 5.594

Review 7.  Predictive factors of short term outcome after liver transplantation: A review.

Authors:  Giuliano Bolondi; Federico Mocchegiani; Roberto Montalti; Daniele Nicolini; Marco Vivarelli; Lesley De Pietri
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

8.  Liver transplantation in adults: Choosing the appropriate timing.

Authors:  Maria Siciliano; Lucia Parlati; Federica Maldarelli; Massimo Rossi; Stefano Ginanni Corradini
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-08-06

Review 9.  Current strategies for immunosuppression following liver transplantation.

Authors:  Daniel Nils Gotthardt; Helge Bruns; Karl Heinz Weiss; Peter Schemmer
Journal:  Langenbecks Arch Surg       Date:  2014-04-20       Impact factor: 3.445

Review 10.  Living donor liver transplantation in Europe.

Authors:  Silvio Nadalin; Ivan Capobianco; Fabrizio Panaro; Fabrizio Di Francesco; Roberto Troisi; Mauricio Sainz-Barriga; Paolo Muiesan; Alfred Königsrainer; Giuliano Testa
Journal:  Hepatobiliary Surg Nutr       Date:  2016-04       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.